These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4014830)

  • 41. Identification of bovine carriers of Moraxella bovis by comparative cultural examinations of ocular and nasal secretions.
    Pugh GW; McDonald TJ
    Am J Vet Res; 1986 Nov; 47(11):2343-5. PubMed ID: 3789493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infectious bovine keratoconjunctivitis: bacteriologic, immunologic, and clinical responses of cattle to experimental exposure with Moraxella bovis.
    Weech GM; Renshaw HW
    Comp Immunol Microbiol Infect Dis; 1983; 6(1):81-94. PubMed ID: 6825419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity of Moraxella bovis hemolysin.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1985 May; 46(5):1011-4. PubMed ID: 2408520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serologic response of vaccinated cattle to strains of Moraxella bovis isolated during epizootics of keratoconjunctivitis.
    Pugh GW; Hughes DE; Booth GD
    Am J Vet Res; 1978 Jan; 39(1):55-7. PubMed ID: 415645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of long-acting oxytetracycline in the immunisation of cattle against Babesia bovis and B bigemina.
    Pipano E; Markovics A; Kriegel Y; Frank M; Fish L
    Res Vet Sci; 1987 Jul; 43(1):64-6. PubMed ID: 3628985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of salinomycin in treatment of experimental Eimeria bovis infections in calves.
    Benz GW; Ernst JV
    Am J Vet Res; 1979 Aug; 40(8):1180-6. PubMed ID: 525921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infectious bovine keratoconjunctivitis: influence of age on development of disease in vaccinated and nonvaccinated calves after exposure to Moraxella bovis.
    Pugh GW; McDonald TJ; Booth GD
    Am J Vet Res; 1979 Jun; 40(6):762-6. PubMed ID: 475126
    [No Abstract]   [Full Text] [Related]  

  • 50. Detection of Moraxella bovis antibodies in infectious bovine keratoconjunctivitis by a passive hemagglutination test.
    Arora AK; Killinger AH; Myers WL
    Am J Vet Res; 1976 Dec; 37(12):1489-92. PubMed ID: 999074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular and serum disposition kinetics of cloxacillin after topical administration of benzathine cloxacillin and intravenous administration of sodium cloxacillin to calves.
    Daigneault J; George LW; Baggot JD
    Am J Vet Res; 1990 Mar; 51(3):381-5. PubMed ID: 2316914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of Hydrotaea armipes Fall. (Diptera, Muscidae) in the transmission of infectious bovine keratoconjunctivitis.
    Dusbábek F; Soukupová A; Gregor F; Krejcí J
    Folia Parasitol (Praha); 1982; 29(1):79-83. PubMed ID: 7061022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scanning electron microscopy of bovine corneas irradiated with sun lamps and challenge exposed with Moraxella bovis.
    Vogelweid CM; Miller RB; Berg JN; Kinden DA
    Am J Vet Res; 1986 Feb; 47(2):378-84. PubMed ID: 3954223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infectious bovine keratoconjunctivitis: comparison of infection, signs of disease and weight gain in vaccinated versus nonvaccinated purebred Hereford heifer calves.
    Pugh GW; McDonald TJ; Kopecky KE; Kvasnicka WG
    Can J Vet Res; 1986 Apr; 50(2):259-64. PubMed ID: 3756679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enzyme-linked immunosorbent assay for measurement of anti-Moraxella bovis antibodies.
    Bishop B; Schurig GG; Troutt HF
    Am J Vet Res; 1982 Aug; 43(8):1443-5. PubMed ID: 7049023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis.
    Magonigle RA; Simpson JE; Frank FW
    Am J Vet Res; 1978 Sep; 39(9):1407-10. PubMed ID: 697150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infectious bovine keratoconjunctivitis: contact transmission.
    Kopecky KE; Pugh GW; McDonald TJ
    Am J Vet Res; 1986 Mar; 47(3):622-4. PubMed ID: 3963562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized blinded challenge study to assess association between Moraxella bovoculi and Infectious Bovine Keratoconjunctivitis in dairy calves.
    Gould S; Dewell R; Tofflemire K; Whitley RD; Millman ST; Opriessnig T; Rosenbusch R; Trujillo J; O'Connor AM
    Vet Microbiol; 2013 May; 164(1-2):108-15. PubMed ID: 23452750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.